<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>beta 2 glycoprotein 1 (beta2GP1) is a <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding protein implicated in the development of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, associated with thromboembolic complications and fetal morbidity and <z:hpo ids='HP_0011420'>death</z:hpo>, and is thought to corrrelate better than anticardiolipin (aCL) assays </plain></SENT>
<SENT sid="1" pm="."><plain>We analysed the role of beta2GP1 in assessing 86 patients being investigated for <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-nine patients had 3 tests: [<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), aCL and beta2GP1], and a further 46 had aCL and beta2GP1 </plain></SENT>
<SENT sid="3" pm="."><plain>Sixty-one patients had completely negative tests </plain></SENT>
<SENT sid="4" pm="."><plain>Five patients had beta2GP1 as the only positive result </plain></SENT>
<SENT sid="5" pm="."><plain>80% of this group had <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> suggesting that beta2GP1 may be an useful adjunct to aCL and LA testing in patients with a significant obstetric history </plain></SENT>
</text></document>